Saleh Arman Yurisaldi, Valentina Riezky, Susanto Tirta Darmawan, Saputra Dwi Arwandi Yogi
Neurology Department Faculty of Medicine, UPN Veteran Jakarta, Jakarta, Special Capital Region of Jakarta, 12450, Indonesia.
Family Medicine and Primary Care, Universitas Pelita Harapan, Tangerang, Banten, 15811, Indonesia.
F1000Res. 2025 Sep 18;13:799. doi: 10.12688/f1000research.152581.2. eCollection 2024.
NeuroAiD, also known as MLC601 or MLC901, is a Chinese herbal combination used worldwide for stroke treatment. It contains herbal components and five hewan components. MLC601 contains herbal components and hewan components, while MLC901 has a similar herbal composition. NeuroAiD is used to support neurologic recovery after stroke and to aid cognitive function in Alzheimer's disease. Studies show that NeuroAiD has potential in treating Alzheimer's disease and is beneficial in both local and global stroke models and in the Kortikal culture. However, there is limited bibliometric research on NeuroAiD, which is a method of collecting data from published articles to analyze developments and trends in the field of research. This research contributes significantly to the literature and helps develop more effective stroke treatment strategies.
In this work, a literature review methodology is employed to gather data from the Scopus database using the keywords neuroaid. Data were analyzed using Biblioshiny and VOSviewer software to produce visualizations and bibliometric maps. We conducted quantitative and qualitative analysis.
The research trend found are documents by year, most relevant sources, factorial map of the most cited documents, factorial map of The documents with the highest contributes, documents by author, documents by country or territory, documents by subject area, documents by affiliation, network visualization, overlay visualization of scopus database using vosviewer, density visualization, thematic map, thematic evolution, topic dendogram, and world cloud.
The study investigates the potential of Neuroaid, a neuroprotective drug, for stroke prevention and cognitive function enhancement. It uses terms like "cognition" and "neurogenesis" to highlight its potential. While the study's focus may be limited, it provides valuable insights into research direction and potential areas of neuroaid for stroke treatment.
NeuroAiD,也被称为MLC601或MLC901,是一种在全球范围内用于治疗中风的中药复方。它包含草药成分和五种合丸成分。MLC601含有草药成分和合丸成分,而MLC901具有相似的草药组成。NeuroAiD用于支持中风后的神经功能恢复,并辅助治疗阿尔茨海默病的认知功能。研究表明,NeuroAiD在治疗阿尔茨海默病方面具有潜力,并且在局部和整体中风模型以及皮质培养中均有益处。然而,关于NeuroAiD的文献计量研究有限,文献计量学是一种从已发表文章中收集数据以分析研究领域发展和趋势的方法。本研究对文献做出了重大贡献,并有助于制定更有效的中风治疗策略。
在本研究中,采用文献综述方法,使用关键词“neuroaid”从Scopus数据库收集数据。使用Biblioshiny和VOSviewer软件对数据进行分析,以生成可视化结果和文献计量图。我们进行了定量和定性分析。
发现的研究趋势包括逐年文献、最相关来源、被引次数最多文献的因子图、贡献最高文献的因子图、作者文献、国家或地区文献、主题领域文献、机构文献、网络可视化、使用vosviewer对Scopus数据库的叠加可视化、密度可视化、主题图、主题演变、主题树状图和词云。
该研究调查了神经保护药物Neuroaid在预防中风和增强认知功能方面的潜力。它使用“认知”和“神经发生”等术语来突出其潜力。虽然该研究的重点可能有限,但它为中风治疗的Neuroaid研究方向和潜在领域提供了有价值的见解。